Cargando…

Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images

Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be b...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chih-Ling, Lian, Meng-Jia, Wu, Yi-Hsuan, Chen, Wei-Ming, Chiu, Wen-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345158/
https://www.ncbi.nlm.nih.gov/pubmed/32527052
http://dx.doi.org/10.3390/diagnostics10060389
_version_ 1783556115400753152
author Huang, Chih-Ling
Lian, Meng-Jia
Wu, Yi-Hsuan
Chen, Wei-Ming
Chiu, Wen-Tai
author_facet Huang, Chih-Ling
Lian, Meng-Jia
Wu, Yi-Hsuan
Chen, Wei-Ming
Chiu, Wen-Tai
author_sort Huang, Chih-Ling
collection PubMed
description Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be beneficial to identify chemoresistance for ovarian adenocarcinoma cells, especially CP-resistance. Gray level co-occurrence matrix (GLCM) was characterized imaging from a numeric matrix and find its texture features. Serous type (OVCAR-4 and A2780), and clear cell type (IGROV1) ovarian carcinoma cell lines with CP-resistance were used to demonstrate GLCM texture feature extraction of images. Cells were cultured with cell density of 6 × 10(5) in a glass-bottom dish to form a uniform coverage of the glass slide to get the optical images by microscope and DVC camera. CP-resistant cells included OVCAR-4, A2780 and IGROV and had the higher contrast and entropy, lower energy, and homogeneity. Signal to noise ratio was used to evaluate the degree for chemoresistance of cell images based on GLCM texture feature extraction. The difference between wile type and CP-resistant cells was statistically significant in every case (p < 0.001). It is a promising model to achieve a rapid method with a more reliable diagnostic performance for identification of ovarian adenocarcinoma cells with CP-resistance by feature extraction of GLCM in vitro or ex vivo.
format Online
Article
Text
id pubmed-7345158
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73451582020-07-09 Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images Huang, Chih-Ling Lian, Meng-Jia Wu, Yi-Hsuan Chen, Wei-Ming Chiu, Wen-Tai Diagnostics (Basel) Article Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be beneficial to identify chemoresistance for ovarian adenocarcinoma cells, especially CP-resistance. Gray level co-occurrence matrix (GLCM) was characterized imaging from a numeric matrix and find its texture features. Serous type (OVCAR-4 and A2780), and clear cell type (IGROV1) ovarian carcinoma cell lines with CP-resistance were used to demonstrate GLCM texture feature extraction of images. Cells were cultured with cell density of 6 × 10(5) in a glass-bottom dish to form a uniform coverage of the glass slide to get the optical images by microscope and DVC camera. CP-resistant cells included OVCAR-4, A2780 and IGROV and had the higher contrast and entropy, lower energy, and homogeneity. Signal to noise ratio was used to evaluate the degree for chemoresistance of cell images based on GLCM texture feature extraction. The difference between wile type and CP-resistant cells was statistically significant in every case (p < 0.001). It is a promising model to achieve a rapid method with a more reliable diagnostic performance for identification of ovarian adenocarcinoma cells with CP-resistance by feature extraction of GLCM in vitro or ex vivo. MDPI 2020-06-09 /pmc/articles/PMC7345158/ /pubmed/32527052 http://dx.doi.org/10.3390/diagnostics10060389 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huang, Chih-Ling
Lian, Meng-Jia
Wu, Yi-Hsuan
Chen, Wei-Ming
Chiu, Wen-Tai
Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
title Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
title_full Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
title_fullStr Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
title_full_unstemmed Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
title_short Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
title_sort identification of human ovarian adenocarcinoma cells with cisplatin-resistance by feature extraction of gray level co-occurrence matrix using optical images
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345158/
https://www.ncbi.nlm.nih.gov/pubmed/32527052
http://dx.doi.org/10.3390/diagnostics10060389
work_keys_str_mv AT huangchihling identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages
AT lianmengjia identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages
AT wuyihsuan identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages
AT chenweiming identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages
AT chiuwentai identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages